New study aims to improve heart valve replacement for tricky bicuspid cases

NCT ID NCT07450196

First seen Mar 12, 2026 · Last updated May 15, 2026 · Updated 5 times

Summary

This study looks at how safe and effective the SAPIEN 3 heart valve is for people with a certain type of bicuspid aortic valve (Type-0) that causes narrowing. About 170 people in China will be observed after the procedure to track serious problems like death, stroke, or needing to go back to the hospital. The goal is to see if this valve works well for this challenging heart condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing

    Beijing, Beijing Municipality, 100037, China

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.